Literature DB >> 23423512

Recent advances in research on epigenetic alterations and clinical significance of para-aortic lymphadenectomy in endometrial cancer: an introduction.

Noriaki Sakuragi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23423512     DOI： 10.1007/s10147-013-0535-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


× No keyword cloud information.
  26 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Nodal spread in relation to penetration and differentiation.

Authors:  B V Lewis
Journal:  Proc R Soc Med       Date:  1971-04

3.  Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.

Authors:  Janiel M Cragun; Laura J Havrilesky; Brian Calingaert; Ingrid Synan; Angeles Alvarez Secord; John T Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

4.  Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer.

Authors:  Noriaki Sakuragi; Hidemichi Watari; Yasuhiko Ebina; Ritsu Yamamoto; Eric Steiner; Heinz Koelbl; Masahiro Yano; Mitsuhiro Tada; Tetsuya Moriuchi
Journal:  Int J Cancer       Date:  2005-09-10       Impact factor: 7.396

5.  p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review.

Authors:  Eun-Ju Lee; Tae-Joong Kim; Dae Shick Kim; Chel Hun Choi; Jeong-Won Lee; Je-Ho Lee; Duk-Soo Bae; Byoung-Gie Kim
Journal:  Gynecol Oncol       Date:  2009-12-14       Impact factor: 5.482

6.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

Review 7.  Stage I-II endometrial adenocarcinoma evolution of therapeutic paradigms: the role of surgery and adjuvant radiation.

Authors:  Katherine Look
Journal:  Int J Gynecol Cancer       Date:  2002 May-Jun       Impact factor: 3.437

Review 8.  New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review).

Authors:  Kiyoko Umene; Kouji Banno; Iori Kisu; Megumi Yanokura; Yuya Nogami; Kosuke Tsuji; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Rep       Date:  2013-01-03       Impact factor: 3.906

9.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

10.  Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Authors:  P Dong; M Karaayvaz; N Jia; M Kaneuchi; J Hamada; H Watari; S Sudo; J Ju; N Sakuragi
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.